Press and Media

Filter by


1,000 radiation therapy centers choose myQA®

myQA® has been selected by 1,000 customers around the world as their trusted global QA platform to integrate quality assurance applications, people, and know-how.

Read more

ICC training course « Small Fields and FFF » has been accredited by EBAMP

IBA Dosimetry successfully passed the evaluation for its ICC training course “Small Fields and FFF: The New Regulation DIN 6809-8 in Theory and Hands-on Practice.” This is the first training for which IBA applied for accreditation under the new procedure set by the European Federation of Medical Physics Associations (EFOMP).

Read more

IBA releases the newest version of myQA® Global Platform for Integrated Quality Assurance

The newest release of myQA, enables users to integrate IBA’s Dolphin Transmission Detector measurements into their linac machine QA dosimetry tests. This also provides an easy comparison of results and efficient trend analysis.

Read more

IBA Dolphin® Patient Treatment QA Solution First Clinical Use In Japan

Osaka International Cancer Institute has successfully validated and clinically implemented the Dolphin transmission detector system. With the use of Dolphin, the team opened a new area of QA standard for improved efficiency and treatment quality in radiation therapy. To address the special high demands of SRS and SBRT cases the hospital’s team has clinically implemented Dolphin due to the system’s ability to verify treatment doses in 3D within the patient’s individual anatomy...

Read more

IBA Trading Update - First Quarter 2017

IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today provides trading update for the first quarter ending 31 March 2017.

Read more

IBA Dosimetry Americas Grows in Canada with Exclusive Distributor, ProMed Technologies

IBA Dosimetry Americas announces ProMed Technologies as their new, exclusive distributor partner for Canada, ensuring quality sales service in each province.

Read more

IBA Reports Full Year Results for 2016

IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces its audited consolidated annual results for the 2016 financial year.

Read more

Dolphin® used in Turkey for SRS and SBRT treatment Quality Assurance for safer Radiation Therapy

With the use of Dolphin, the team at the Gaziosmanpasa Hospital in Istanbul, Turkey, implemented a new quality assurance standard for challenging radiosurgery and Stereotactic Body Radiation Therapy (SBRT) cases. These patient treatments are delivered with high doses typically in five or less treatment fractions precisely tailored to the tumor’s shape and location.

Read more

IBA Releases Dolphin® Online Ready Transmission Detector

To achieve added efficiency, Dolphin offers a “plug and play” design that enables significantly faster pre-treatment QA. Dolphin only requires two minutes to set up and wirelessly transmits the measured detector response to the Dolphin workstation. Additionally, the new automatic quick verification software functionality saves valuable time by providing instant analysis of the Dolphin measurements and giving an “OK” message for the tests successfully passed...

Read more

IBA Releases 3rd myQA® Version

With this new release, Relative Dosimetry is now connected to myQA® along with the already released Machine QA and Patient QA. One key innovation is that hospitals can now benchmark their individual data compared to other gold standard scans to ensure high confidence in Linac commissioning and QA accuracy...

Read more
1 / 4